ZA919480B - 5-amino-5,6,7,8-tetrahydrouquinolines and related compounds,a process for their preparation and their use as medicaments - Google Patents

5-amino-5,6,7,8-tetrahydrouquinolines and related compounds,a process for their preparation and their use as medicaments

Info

Publication number
ZA919480B
ZA919480B ZA919480A ZA919480A ZA919480B ZA 919480 B ZA919480 B ZA 919480B ZA 919480 A ZA919480 A ZA 919480A ZA 919480 A ZA919480 A ZA 919480A ZA 919480 B ZA919480 B ZA 919480B
Authority
ZA
South Africa
Prior art keywords
arylalkyl
alkyl
formula
hydrogen
chem
Prior art date
Application number
ZA919480A
Other languages
English (en)
Inventor
Richard Charles Effland
Charles Effland Richard
David M Fink
M Fink David
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of ZA919480B publication Critical patent/ZA919480B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Quinoline Compounds (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA919480A 1990-12-03 1991-12-02 5-amino-5,6,7,8-tetrahydrouquinolines and related compounds,a process for their preparation and their use as medicaments ZA919480B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/620,811 US5110815A (en) 1990-12-03 1990-12-03 5-amino-5,6,7,8-tetrahydroquinolines and related compounds and pharmaceutical use

Publications (1)

Publication Number Publication Date
ZA919480B true ZA919480B (en) 1992-08-26

Family

ID=24487491

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA919480A ZA919480B (en) 1990-12-03 1991-12-02 5-amino-5,6,7,8-tetrahydrouquinolines and related compounds,a process for their preparation and their use as medicaments

Country Status (17)

Country Link
US (2) US5110815A (de)
EP (1) EP0489379B1 (de)
JP (1) JP3090514B2 (de)
KR (1) KR100235506B1 (de)
AT (1) ATE168371T1 (de)
AU (1) AU639875B2 (de)
CA (1) CA2056793C (de)
DE (1) DE69129790T2 (de)
DK (1) DK0489379T3 (de)
ES (1) ES2119752T3 (de)
FI (1) FI915653A7 (de)
IE (1) IE914183A1 (de)
NO (1) NO914734L (de)
NZ (1) NZ240803A (de)
PT (1) PT99674B (de)
TW (1) TW211003B (de)
ZA (1) ZA919480B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL112567A (en) * 1994-02-10 2000-02-29 Wyeth John & Brother Ltd Substituted quinolines their preparation and pharmaceutical compositions containing them
IL112568A0 (en) * 1994-02-10 1995-05-26 Wyeth John & Brother Ltd Substituted quinolines, their preparation and pharmaceutical compositions containing them
IL112566A (en) * 1994-02-10 2000-10-31 Wyeth John & Brother Ltd Substituted quinolinones and pharmaceutical compositions containing them
KR0158065B1 (ko) * 1995-05-29 1998-12-01 스기야마 가즈히코 반도체 집적회로장치 및 그 제조방법
HUP0104493A3 (en) 1998-09-30 2002-12-28 Takeda Pharmaceutical Drugs for improving vesical excretory strength
TWI301760B (en) * 2004-02-27 2008-10-11 Merz Pharma Gmbh & Co Kgaa Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4789678A (en) * 1986-08-25 1988-12-06 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing α-alkyl-4-amino-3-quinolinemethanols and 1-(4-aralkylamino-3-quinolinyl)alkanones and related compounds
US4942168A (en) * 1987-07-13 1990-07-17 Hoechst-Roussel Pharmaceuticals Inc. Hydroxyquinoline amines, and method of enhancing memory in mammals
EP0361489A3 (de) * 1988-09-30 1991-06-12 Chugai Seiyaku Kabushiki Kaisha 3,4-Diaminochinolin- und Pyridinverbindungen
JPH0322011A (ja) * 1989-06-19 1991-01-30 Nec Corp キーボード入力データ処理方式

Also Published As

Publication number Publication date
JP3090514B2 (ja) 2000-09-25
KR100235506B1 (ko) 1999-12-15
FI915653A0 (fi) 1991-11-29
ATE168371T1 (de) 1998-08-15
US5110815A (en) 1992-05-05
IE914183A1 (en) 1992-06-03
NO914734D0 (no) 1991-12-02
CA2056793A1 (en) 1992-06-04
TW211003B (de) 1993-08-11
CA2056793C (en) 2003-03-11
NZ240803A (en) 1994-07-26
AU639875B2 (en) 1993-08-05
KR920012036A (ko) 1992-07-25
AU8835291A (en) 1992-06-04
PT99674B (pt) 1999-05-31
DE69129790D1 (de) 1998-08-20
DE69129790T2 (de) 1999-05-06
DK0489379T3 (da) 1999-04-19
ES2119752T3 (es) 1998-10-16
NO914734L (no) 1992-06-04
EP0489379B1 (de) 1998-07-15
US5310914A (en) 1994-05-10
PT99674A (pt) 1992-10-30
JPH04290872A (ja) 1992-10-15
FI915653A7 (fi) 1992-06-04
EP0489379A1 (de) 1992-06-10

Similar Documents

Publication Publication Date Title
HUT54357A (en) Process for producing benzilidene-(azolylmethyl)-cycloalkane and -cycloalkene derivatives, fungicidal compositions comprising such compounds as active ingredient and intermediates usable for the production of the active ingredients
GB8919434D0 (en) Novel compounds
EP0437030A3 (en) Use of 4-substituted imidazoles for lowering intraocular pressure
SG49607A1 (en) 1-methylcarbapenem derivatives and process for preparation thereof
PL309874A1 (en) Novel derivatives of pyrrolocarbasol, method of obtaining them and pharmaceutical composition containing such derivatives
GR3007401T3 (de)
HUT50349A (en) Process for production of new cefem-compositions
AU639875B2 (en) 5-amino-5,6,7,8-tetrahydroquinolines and related compounds and pharmaceutical use
LV10235B (en) New esters, method of preparation thereof, pharmaceutical composition and method of treatment
EP0408044A3 (en) Anti-inflammatory and/or anti-allergic composition comprising glutathione derivatives
IL89908A0 (en) 2-alkyl-3-benzoylbenzofurans and pharmaceutical compositions containing them
HUT50337A (en) Process for producing benzoxazine derivatives and pharmaceutical compositions comprising the compounds
GR3007219T3 (de)
IE901104L (en) New bronchospasmolytic compounds and process for their¹preparation
AU581440B2 (en) Benzoseleno ``4,3,2-cd`` indazole compositions and methods for their production and use
IL87107A0 (en) Naphthothiazepine derivatives,their preparation and pharmaceutical compositions containing them
MY101746A (en) 1,5-benzothiazepine derivatives, a process for preparing the same, pharmaceutical compositions as well as the use thereof.